RemSleep Holdings (RMSL) Shares Outstanding (Diluted Average) (2019 - 2025)
RemSleep Holdings recorded quarterly Shares Outstanding (Diluted Average) of $1.6 billion in Q4 2025, down 0.59% quarter-over-quarter from $1.6 billion in Q3 2025, and up 6.18% year-over-year from $1.5 billion in Q4 2024.
RemSleep Holdings' Shares Outstanding (Diluted Average) history runs 7 years deep, the most recent figure standing at $1.6 billion for Q4 2025.
- In Q4 2025, Shares Outstanding (Diluted Average) rose 6.18% year-over-year to $1.6 billion; the TTM figure through Dec 2025 stood at $1.6 billion (up 6.18% YoY), while the FY2025 annual figure was $1.6 billion, up 6.18% from the prior year.
- Shares Outstanding (Diluted Average) came in at $1.6 billion for Q4 2025 at RemSleep Holdings, down from $1.6 billion in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $1.6 billion in Q3 2025 to a low of $513.8 million in Q2 2021.
- A 5-year average of $1.3 billion and a median of $1.5 billion in 2022 frame the typical range for Shares Outstanding (Diluted Average).
- Across the five-year window, Shares Outstanding (Diluted Average) surged 208.96% in 2021 and decreased 0.02% in 2023, its largest moves.
- RemSleep Holdings' Shares Outstanding (Diluted Average) stood at $700.9 million in 2021, then jumped by 108.59% to $1.5 billion in 2022, then slipped by 0.02% to $1.5 billion in 2023, then gained by 1.02% to $1.5 billion in 2024, then advanced by 6.18% to $1.6 billion in 2025.
- According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods registered $1.6 billion, $1.6 billion, and $1.5 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | RemSleep Holdings | - | - | -7,636.00 | 1.57 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.57 Bn |
| Sep 30, 2025 | 1.58 Bn |
| Jun 30, 2025 | 1.54 Bn |
| Mar 31, 2025 | 1.53 Bn |
| Dec 31, 2024 | 1.48 Bn |
| Sep 30, 2024 | 1.48 Bn |
| Jun 30, 2024 | 1.47 Bn |
| Mar 31, 2024 | 1.46 Bn |
| Dec 31, 2023 | 1.46 Bn |
| Sep 30, 2023 | 1.46 Bn |
| Jun 30, 2023 | 1.46 Bn |
| Mar 31, 2023 | 1.46 Bn |
| Dec 31, 2022 | 1.46 Bn |
| Sep 30, 2022 | 1.46 Bn |
| Jun 30, 2022 | 1.43 Bn |
| Mar 31, 2022 | 1.38 Bn |
| Dec 31, 2021 | 700.90 Mn |
| Sep 30, 2021 | 569.84 Mn |
| Jun 30, 2021 | 513.77 Mn |
| Jun 30, 2020 | 166.29 Mn |
| Jun 30, 2019 | 13.11 Mn |